Discussing surgical innovation with patients: A qualitative study of surgeons’ and governance representatives’ views by Zahra, J et al.
                          Zahra, J., Paramasivan, S., Blencowe, N. S., Cousins, S., Avery, K.,
Mathews, J., Main, B., McNair, A., Hinchliffe, R., Blazeby, J. M., &
Elliott, D. (2020). Discussing surgical innovation with patients: A
qualitative study of surgeons’ and governance representatives’ views.
BMJ Open, 10(11), [e035251]. https://doi.org/10.1136/bmjopen-2019-
035251
Publisher's PDF, also known as Version of record
License (if available):
CC BY
Link to published version (if available):
10.1136/bmjopen-2019-035251
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via BMJ at
http://dx.doi.org/10.1136/bmjopen-2019-035251. Please refer to any applicable terms of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/
1Zahra J, et al. BMJ Open 2020;10:e035251. doi:10.1136/bmjopen-2019-035251
Open access 
Discussing surgical innovation with 
patients: a qualitative study of surgeons’ 
and governance representatives’ views
Jesmond Zahra   ,1,2 Sangeetha Paramasivan,1,2 Natalie S Blencowe   ,1,2,3 
Sian Cousins,1,2 Kerry Avery   ,1,2 Johnny Mathews,1,2 Barry G Main,1,2,4 
Angus G K McNair   ,1,2,5 Robert Hinchliffe,1,2,6 Jane M Blazeby,1,2,4 Daisy Elliott1,2
To cite: Zahra J, Paramasivan S, 
Blencowe NS, et al.  Discussing 
surgical innovation with 
patients: a qualitative 
study of surgeons’ and 
governance representatives’ 
views. BMJ Open 
2020;10:e035251. doi:10.1136/
bmjopen-2019-035251
 ► Prepublication history and 
additional material for this 
paper are available online. To 
view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2019- 
035251).
Received 24 October 2019
Revised 18 August 2020
Accepted 25 September 2020
For numbered affiliations see 
end of article.
Correspondence to
Dr Daisy Elliott;  
 daisy. elliott@ bristol. ac. uk
Original research
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY. 
Published by BMJ.
ABSTRACT
Objectives Little is known about how innovative surgical 
procedures are introduced and discussed with patients. 
This qualitative study aimed to explore perspectives on 
information provision and consent prior to innovative 
surgical procedures.
Design Qualitative study involving semi- structured 
interviews. Interviews were audio recorded, transcribed 
and analysed thematically.
Participants 42 interviews were conducted (26 surgeons 
and 16 governance representatives).
Setting Surgeons and governance representatives 
recruited from various surgical specialties and National 
Health Service (NHS) Trusts across England, UK.
Results Participants stated that if a procedure was 
innovative, patients should be provided with additional 
information extending beyond that given during routine 
surgical consultations. However, difficulty defining 
innovation had implications for whether patients were 
informed about novel components of surgery and how 
the procedure was introduced (ie, as part of a research 
study, trust approval or in routine clinical practice). 
Furthermore, data suggest surgeons found it difficult to 
establish what information is essential and how much 
detail is sufficient, and governance surrounding written 
and verbal information provision differed between NHS 
Trusts. Generally, surgeons believed patients held a view 
that ‘new’ was best and reported that managing these 
expectations could be difficult, particularly if patient views 
aligned with their own.
Conclusions This study highlights the challenges of 
information provision and obtaining informed consent in 
the context of innovative surgery, including establishing 
if and how a procedure is truly innovative, determining 
the key information to discuss with patients, ensuring 
information provision is objective and balanced, and 
managing patient expectations and preferences. This 
suggests that surgeons may require support and training 
to discuss novel procedures with patients. Further work 
should capture consultations where new procedures 
are discussed with patients and patients’ views of these 
information exchanges.
INTRODUCTION
Informed consent is fundamental to patient 
autonomy and represents a cornerstone of 
modern healthcare provision. Until recently, 
the Bolam ruling meant that a doctor’s duty 
to inform patients prior to surgery was judged 
based on whether they had acted in line with 
the view of a responsible body of medical 
opinion.1 2 The 2015 Montgomery ruling3 
redefined the standard of informed consent 
in the UK and represented a shift from a 
paternalistic model of consent to a more 
patient- centred approach4 5—meaning that a 
patient should be told whatever they want to 
know, not what the doctor thinks they should 
be told.5
Recently, important questions have been 
raised surrounding informed consent for 
innovative surgical procedures.6 7 An inquest 
into the death of the first patient in the UK 
to undergo robotically assisted heart surgery 
found the patient had not been fully informed 
Strengths and limitations of this study
 ► This is the first qualitative study to conduct in- depth, 
semi- structured interviews to understand current 
practice for information provision and informed con-
sent for innovative surgical procedures in the UK.
 ► Interviews with governance representatives enabled 
us to understand what policies were in place for the 
introduction of new procedures, while surgeons pro-
vided insights into how they introduced new proce-
dures and discussed these with patients.
 ► Purposeful sampling ensured that participants were 
recruited from a range of geographical locations and 
trust types, and surgeons were from different spe-
cialties with varying experiences of innovation.
 ► Audio- recording appointments where clinicians 
discuss innovative surgeries and patients decide 
whether or not to undergo the procedure would 
strengthen our understanding of interactions be-
tween clinicians and patients.
 ► Further work should capture patients’ views on in-
formation provision in this context, so that recom-
mendations can be made to improve transparency 
and communication.
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about the comparative risk of robotic versus conventional 
open surgery.7 In addition, a summary of invited reviews 
published by the Royal College of Surgeons of England 
(RCSEng) raised further concerns.6 The review high-
lighted issues surrounding surgeons’ ability to accurately 
quantify risk as reported in published literature, whether 
surgical experience is being sufficiently disclosed and 
effectively communicated to patients, and the overall 
quality of patient–clinician discussions.6 The RESEng 
subsequently published guidelines for the development, 
implementation and dissemination of surgical innova-
tion, which contain guidance on informed consent.8 This 
suggests, based on findings of a review by Broekman et 
al,8 that patients should be informed of the innovative 
nature of the procedure, surgeons’ experience with the 
procedure and the learning curve, the risk and benefits—
including unknown or unforeseeable risks or outcomes, 
the evidence or lack thereof, and alternatives to the inno-
vative procedure.
Reviews and commentaries have highlighted potential 
issues around informed consent for innovative surgical 
procedures, including patients’ and surgeons’ beliefs 
that new treatments constitute improved treatment 
options or result in better outcomes.9 10 However, little 
is known about current practice. Surveys that have been 
conducted in the USA suggest that information varies 
considerably in content and quality. Reitsma and Moreno 
reported that of 21 surgeons, 75% verbally informed 
patients about the innovative nature of the procedure but 
only 33% provided written information.11 Lee et al, in a 
scenario- based survey carried out with 85 surgeons and 
383 patients, found differences between what surgeons 
thought patients wanted to know about innovative proce-
dures and what patients reported they wanted to know. 
For instance, compared with surgeons, patients placed 
more importance on nearly all types of information, 
particularly volumes and outcomes.12
While a handful of qualitative studies have been 
conducted exploring how innovative procedures have 
been introduced,13–16 none have specifically looked at 
information provision and informed consent. More-
over, these studies were conducted in Australia and 
Canada and findings may not be generalisable to other 
countries and different healthcare systems.17 New inva-
sive procedures may be introduced in the context of 
formal research studies or via local hospital policies.18 
The National Institute for Health and Care Excellence 
(NICE) recommends that local National Health Service 
(NHS) organisations have appropriate governance 
structures in place to review, approve and monitor the 
introduction of new invasive procedures.19 The current 
study sought to explore surgeons’ and governance repre-
sentatives’ views of information provision and informed 
consent for the introduction of new invasive procedures 
in the UK.
METHODS
Patient and public involvement
Public and patient involvement was not conducted as part 
of the current study. However, the current findings have 
been discussed with a recently established group, which 
has led to further work which specifically aims to explore 
patient views on surgical innovation.
Design
This qualitative study employed a grounded theory meth-
odology20 because it enabled the inductive identification 
of codes from the data to generate new hypotheses about 
phenomena that are derived or grounded in the data.21 
Its central principle is of constant comparison, where new 
findings are systematically compared with existing data 
so that similarities and differences can be identified and 
emerging theories refined through the ongoing assimila-
tion of data.20 22 Consistent with grounded theory meth-
odology, semi- structured interviews were conducted with 
relevant stakeholders.
Ethical approval was granted by the University of Bristol 
Faculty of Health Sciences Research Ethics Committee. 
The study is reported in line with the Standards for 
Reporting Qualitative Research (online supplemental file 
1).23
Sampling and recruitment
Participants were recruited between November 2017 and 
October 2018 using a combination of purposive24 and 
snowball sampling techniques.25 Governance representa-
tives (defined as those involved in regulating the intro-
duction of new/modified procedures and/or devices at 
trust or national levels) were included to understand what 
processes were in place for the introduction of new proce-
dures.16 Surgeons were recruited to explore experiences 
of introducing new/modified procedures or devices into 
clinical practice. As there is no standardised definition 
for innovation and it is often a continuum from standard 
practice through to true innovation,13 26 27 and because 
surgical innovation is unlikely to involve a single discrete 
development,28 29 participants were asked to reflect what 
the term meant to them and describe procedures that 
they deemed to be innovative.
Governance representatives were identified through 
websites (eg, NHS Trusts websites) and NHS policy docu-
ments (eg, new invasive procedure/devices policies). An 
initial sample of surgeons was identified by academic 
surgeons working within the Centre for Surgical 
Research, University of Bristol, UK. Subsequent surgeons 
were identified via snowball sampling,25 in which inter-
viewees recommended others who may be willing to take 
part. Sampling was regularly reviewed to ensure surgeons 
from different specialties and geographical locations, 
with varying experiences of innovation (eg, minor modi-
fications vs first in human procedures), were recruited 
to capture a diversity of perspectives.30 31 For governance 
representatives, maximum variation was sought in rela-
tion to different roles (eg, new procedures committee 
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members, medical directors), geographical locations, 
trust types and different surgical specialties.
Potential participants were approached via email and 
up to three invitation emails were sent before contact 
attempts ceased. In total, 83 potential participants were 
invited to take part (38 surgeons and 45 governance 
representatives). Study recruitment ceased when the 
qualitative team agreed that theoretical saturation had 
been achieved (where no new themes were forthcoming 
from three consecutive interviews).32 33
Data collection
Interviews were considered to be the most appropriate 
method for this study because they provided the oppor-
tunity to encourage participants to think carefully about 
their own experiences34 and enable the interviewer 
to respond and follow up on issues raised by the inter-
viewee.35 Interviews were chosen instead of focus groups 
as it was felt that some individuals may feel intimidated 
at the prospect of discussing their experiences within a 
focus group setting.25
All participants received a study information leaflet and 
provided written consent before taking part. Separate 
topic guides were developed for governance represen-
tatives and surgeons. All interview schedules contained 
core topics of interest (eg, ‘How would you define innova-
tion?’, ‘What does informed consent mean to you?’),36 37 
although these were flexible to allow participants to shape 
the direction of conversations.38 39 Governance repre-
sentatives were asked how applications for new invasive 
procedures were processed and how these procedures 
then integrated into practice, whereas surgeons were 
asked about their experiences of introducing proce-
dures and what patients had been told. An example of 
each interview schedule is provided in the online supple-
mental files 2 and 3.
The interviewer began the discussion with more 
general questions to build rapport40 such as the partici-
pants’ background and general views of defining inno-
vation. The interviewee’s comments were restated and 
incorporated into further questions to check with the 
interviewer that they had understood correctly.38 In order 
to gain more detailed and comprehensive understanding 
of the descriptions given by participants, they were asked 
to elaborate their comments with explanations and exam-
ples (such as, ‘Why do you feel this was?’),38 or fillers (such 
as ‘mmm’ or ‘yeah’) were used by the interviewer to show 
the participant this was something they were interested in 
and to encourage them to continue.41 Towards the end 
of the interview, participants were given an opportunity 
to raise issues that were important to them that had not 
already been covered.40
Topic guides were developed iteratively during the 
study period, in consideration of emerging insights from 
interviews and better ways of phrasing questions.36 42 
For instance, interviewers (non- clinical academics) used 
more prompts to encourage the surgeons to describe 
procedures in a non- technical manner.38 Topic guides 
were initially very long so were reduced to include more 
‘mapping’ questions that addressed the core components 
of interest (such as, ‘I understand you’ve conceptualised 
a new procedure. Can you talk me through this?’). Addi-
tional prompts were added from emerging findings (ie, 
colleagues’ reactions to procedures and written informa-
tion). With permission, interviews were audio recorded 
using an encrypted digital dictaphone.
All interviews were audio recorded except one where 
the interviewee requested not to be recorded and 
therefore written notes were taken. All interviews were 
conducted by one of two trained and experienced 
qualitative researchers (JZ or DE). JZ is a male senior 
research associate with a background in public health 
research. DE is a female research fellow with experience 
working on surgical trials. She is also a member of the 
QuinteT research group, which uses qualitative research 
methods to optimise recruitment and informed consent 
to randomised controlled trials (RCTs). JZ and DE 
have several years of experience conducting qualitative 
research, and each has a PhD in health- related research.
Data analysis
Interview recordings were transcribed and de- identi-
fied so that names and identifiable information were 
removed. Data were imported into a data management 
program (NVivo V.11) to organise the data systemati-
cally, allow for quick searching and refining of codes 
and categories, increase the transparency of the anal-
ysis process and enable team comparisons of coding.32 43 
Thematic analysis was undertaken using the constant 
comparison technique of grounded theory.20 44 First, 
analysts (JZ, DE and SP) read and reread transcripts 
before independently coding a sample of five tran-
scripts to begin familiarising themselves with the 
data.32 45 Interesting features were coded, whereby a 
segment of data was assigned a code,42 and ongoing 
potential ideas were noted at every stage of analysis.46 
Data coding was compared to ensure consistency and 
rigour in the findings,47 whereby differences were 
discussed thoroughly until a consensus was met and 
an initial coding frame was developed. The coding 
frame was then independently applied to three tran-
scripts by JZ, DE and SP. High consistency between 
analysts indicated the coding frame appropriately 
captured the data. JZ then applied the coding frame 
to the remaining transcripts, adding additional codes 
if important data were missed by the original coding 
frame. To form preliminary themes and subthemes, 
codes were collated into hierarchical groups.48 
Emerging findings were regularly discussed with JMB 
and NSB (both academic surgeons), with reference 
to the raw transcripts, to ensure they fully encapsu-
lated the meaning of the data.47 Finally, a descriptive 
account of the themes and subthemes, which included 
representative quotes, was developed.
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Of the 83 participants that were approached, 42 partici-
pants were recruited (those who did not participate were 
unable to find time for an interview or did not respond 
to study invites). The final sample included 26 surgeons 
and 16 governance representatives from across 23 NHS 
Trusts. Trusts varied in geographical location, type/size 
(ie, teaching, specialist, large, multicentre) and foun-
dation status. Governance representatives’ roles within 
trusts and NICE varied (eg, medical director, director 
for quality improvement, head of governance), however, 
all played a role in regulating the introduction of new 
surgical procedures and/or devices. At the time of inter-
view, all but one (retired) surgeon worked as a consultant 
within the NHS. Surgical specialties included cardiotho-
racic, gastrointestinal, breast, ophthalmology, neurosur-
gery, urology and orthopaedics. Participants were mostly 
men (87%). Interviews were conducted over the phone 
(55%) or face- to- face at participants’ place of work or at 
a university. Interviews lasted an average of 43 min (range 
22–112 min, SD 17 min).
Analysis
Findings related to informed consent are presented 
under four main themes: difficulty defining inno-
vation, differing views on what—and how—patients 
should be told, the challenges of discussing innovation 
and managing patient expectations. All quotations are 
followed by participants’ unique identification number, 
gender, surgical specialty and trust identification 
number.
Difficulty defining innovation
Surgeons and governance representatives found it chal-
lenging to define surgical innovation and considered the 
term ‘innovation’ to encompass a spectrum of changes 
to surgical healthcare. Examples ranged from changing 
patient pathways through to first in human procedures. 
Consequently many felt innovation should be viewed as a 
continuum, rather than a binary concept:
Well there’s a spectrum isn’t there, I mean it’s diffi-
cult to define. So something that is innovative to me 
is something that is new, it’s a new way of looking at 
it, it’s a slightly different paradigm, a different way of 
thinking. And an adaptation is just a sort of a natural 
evolution of something that’s already pre- existing, I 
suppose that’s how I would define them, but clearly 
it’s a spectrum isn’t it? (Surgeon 18, General Surgery, 
Male, Trust 3)
There was variation in how the procedure had been 
introduced in participants’ hospitals. Within this, 
surgeons’ own experiences included requesting approval 
from their trust’s new procedure committee, conducting 
the procedure in the context of a research study or 
deeming that approval was not necessary as the proce-
dure was a variation of an existing one (from either judge-
ment of the surgeon or confirmation from a committee). 
Table 1 highlights that the challenges of defining innova-
tion, alongside the required technical knowledge of the 
procedure, could cause uncertainty as to what govern-
ance was required.
Although participants initially stated that patients 
should be informed about new procedures, some drew 
Table 1 Participants' experiences of governance for new procedures
Example quote
Procedure considered and approved by trust’s 
new procedure committee
“There’s one surgeon in [European country] who described the procedure, and the 
surgeon in [Asian country] who had done some of these procedures, but not really 
clear on how they’d done it. I contacted the [European] surgeon. He gave me some 
pointers, so I discussed it with my colleagues, and of course put it through the 
governance processes as a novel and a new procedure. And then we did it.” (Surgeon 
31, Colorectal, Male, Trust 8)
Approval from trust’s new procedure 
committee deemed unnecessary as felt to be 
a variation of established procedure
“We asked about it to the new procedures committee, but they said well it’s basically 
[variation of established procedure] isn’t it. The technicalities of it are lost on non- 
thoracic surgeons really, which is good.” (Surgeon 31, General Surgery, Male, Trust 8)
“There’s a new technique that’s probably done by no more than 9 or 10 surgeons in 
the country. Again, it’s a new technique, it’s only been reported in the last 3 or 4 years.
(…)Because it was under the umbrella of [broader procedure), I didn’t have to go 
through any, so within the hospital there’s a board about new techniques, you have to 
sort of, clinical effectiveness group, you have to have that approved. But, because this 
was a variation, we didn’t need that approval.” (Surgeon 22, Male, Orthopaedics, Trust 
7)
Procedure evaluated in the context of a 
research study
“We were looking [procedure], and so that was in the guise of a randomised double- 
blind trial that we put through Ethics. So that would be innovative. We’ve got an 
Ethics Committee, and as part of that if you were going to be doing something really 
brand new that would have to be conducted as part of a trial, so, but when there’s a 
blur between doing something slightly different then no I don’t think it’s the place for 
that(…)I can’t think of anything where they’ve been involved in, you know, anything 
that we’re doing.” (Surgeon 46, Male, Orthopaedics, Trust 22)
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on experiences that contradicted this as they reflected on 
the complexity of defining innovation:
I think absolutely they should be informed, I think 
that’s a tricky one actually… when would I inform a 
patient about a new instrument I was using? So we 
don't- if- if you're not trialling the instrument to see 
if it’s safe or more effective or less effective, then 
I don't think they need to be informed. (Surgeon 
4, Male, General and Upper Gastrointestinal, Trust 
12)
We kind of created our own version of how you do 
that operation […] So, it’s not particularly been de-
scribed before by surgeons and it’s not the world’s 
most different, but it’s got a few little innovative tech-
niques. So, that was an operation we designed that 
was new […] I don’t even explain how that’s different 
to [standard procedure] because I think it’s far too 
technically nuanced for a patient to understand… 
We view it as just a variation of [standard procedure]. 
(Surgeon 22, Thoracic, Male, Trust 7)
Several governance representatives also described 
instances where they had become aware of patients not 
being fully informed about new procedures and empha-
sised the need for improved information provision:
So we then audit the first case to make sure that the 
clinician has been up front with the individual about 
the fact that this is the first time that this particular 
procedure has been undertaken…if they haven’t, 
there’s been a couple of occasions when they haven’t, 
we tell them off and say do better next time and we 
audit the second case or whatever, so we’re confident 
they’ve got it right. (Governance Representative 29, 
Male, Trust 5)
We have had a couple of near misses … one was a 
surgeon inviting another surgeon from another 
hospital to come and show him how to do a proce-
dure, that person did not have an honorary contract 
with the Trust therefore shouldn’t have been oper-
ating and nobody knew that that was occurring. And 
we have had a rep [industry representative] coming 
into theatres to bring some samples of a new piece 
of equipment and most certainly patients weren’t 
consented that it was going to be used on them … So 
I think there is increasing awareness now, certainly 
when business cases are presented, they do need to 
follow this process if that’s what’s going to happen. 
However there is also, can I put my hand on my heart 
and say actually the surgeon’s not going to invite a rep 
into theatre tomorrow? I probably couldn’t, but I do 
know that the theatre staff feel more empowered to 
be able challenge that behaviour, so actually if I knew 
that somebody was going to use a piece of equipment 
they’ve never used before I would probably be asking 
the question as to why. (Surgeon 9, Upper Gastroin-
testinal, Male, Trust 3)
Differing views on what—and how—patients should be told
There was consensus from all participants that if a 
procedure was deemed innovative, patients should be 
provided with additional information extending beyond 
that given during routine surgical consultations. Within 
this, the potential risks and benefits, alternative treat-
ment options and the novel status of the procedure were 
universally regarded as essential information that should 
be discussed.
We tell them that it’s a new procedure and previously 
we’ve told them how many we’ve done prior to this 
(Surgeon 5, Thoracic, Male, Trust 5)
You have to give them options, you have to let them 
know what the evidence base is. (Surgeon 46, Trauma 
and Orthopaedic, Male, Trust 22)
There was variation in views as to whether other infor-
mation—such as the evidence base (or lack thereof), 
operative experience, training, safety precautions imple-
mented in theatre and national guidance—should be 
disclosed. Taken together, there appeared to be uncer-
tainty at precisely how much to tell patients:
Sometimes I tell them too much or tell them… I 
mean, the latest, er, ruling of Montgomery as I un-
derstand it is that they need to be told what they 
would want to know. Bloody hell. But then you've got 
to judge what they want to know and you've got to 
have some kind of communication with them and 
reasonably understand what it is they want to know. 
(Surgeon 31, Colorectal, Male, Trust 8)
There is a difficult balance I think, and I’m not sure 
we’ve got it [consent] right yet actually. (Governance 
Representative 7, Male)
Many interviewees felt strongly that patients should be 
provided with verbal (ie, discussions during consultation) 
and written information (ie, via a patient information 
leaflet (PIL)) when being offered innovative surgery. In 
line with this, most governance representatives reported 
that innovative procedures could only be introduced 
if an appropriate PIL had been developed (although 
there was variation as to whether this was reviewed by the 
committee).
We will insist that there is a patient guide…an infor-
mation sheet for the patient…It [PIL] will talk about 
the relative inexperience of the team, saying that this 
is new to us, but that we’re doing it under conditions 
where we’ve got an expert coming to help us, we’ve 
been to appropriate training, it’s been approved 
by the organisation as something that we think will 
be safe, but that it is a new way of doing things. 
(Governance Representative 24, Male, Trust 9)
However, other trusts had no mandatory requirements 
for written information or did not review written docu-
mentation as part of the application to introduce a new 
procedure:
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Obviously in situations in which the technique might 
be new then that’s (PIL) not something I’ve specifi-
cally addressed but probably should do. (Governance 
Representative 48, Male, Trust 24)
I definitely think they should know it’s a new proce-
dure. The way we probably tell (patients) is only in 
the consent process verbally, I don’t recall seeing that 
in any of our written leaflets. (Governance Represen-
tative 47, Female, Trust 18)
The challenges of discussing innovation
As previously discussed, surgeons felt a need to deliver 
additional information during consultations for innova-
tive surgery. However, data suggest that some surgeons 
may find this challenging:
it’s just trying to get across not only this fact that this 
is what it is, but the fact that it’s newer than some-
thing else which as a standard we use. That’s quite 
difficult trying to get that across, and some patients 
will understand better than others. (Surgeon 42, 
Neurosurgery, Male, Trust 13)
At a practical level, surgeons reported finding it diffi-
cult to establish what information is essential and how 
much detail is enough. These issues may be further 
compounded when faced with time constraints, which 
limit surgeons’ ability to have long and/or multiple 
discussions with patients:
We don’t have much time …I’m finding that I’m 
over talking far too much information, but I need to 
make them aware that they’re essentially guinea pigs. 
(Surgeon 23, Colorectal, Female, Trust 2)
Delivering information to a variety of patients who may 
differ in their ability to understand complex—and poten-
tially very technical—information was a further chal-
lenge. To help overcome this, some surgeons felt it was 
important to simplify technical information and, when 
possible, provide alternative mediums of information to 
aid decision- making:
It’s [surgical procedure] such a complex thing to be 
explaining to people so you have to try and bring it 
down to simplistic terms but at the same time give 
it in a way that actually they can process the salient 
points of the information.’ (Surgeon 46, Trauma and 
Orthopaedic, Male, Trust 22)
I think one of the most important things about when 
you’re making this change is that you give people dif-
ferent forms of access, and of course now it’s easy. 
There are YouTube videos of stuff. (Surgeon 43, 
Orthopaedic, Male, Trust 2)
Surgeons acknowledged that innovative surgery was asso-
ciated with uncertainties, including a lack of knowledge 
surrounding risks, benefits and long- term outcomes. Some 
felt that discussing uncertainties may conflict with the profes-
sional norms within surgery:
This is what surgeons find hard. You have to say, 
“I don't know,” and we hate that. But actually, we 
should say it more often. We should say it more of-
ten. (Surgeon 4, General and Upper Gastrointestinal, 
Male, Trust 12)
As a result, when faced with uncertainty surrounding an 
innovative surgery, surgeons sometimes appeared to disclose 
their personal opinions during patient consultations:
They were told that it was a new technique, that we 
weren’t sure what the long- term outcomes were going to 
be but, we thought that it was better than traditional sur-
gery. (Surgeon 16, Urology, Male, Trust 2)
On the other hand, some expressed a desire to remain 
impartial and stressed the importance of providing balanced 
information. Several interviewees described using strategies 
to help ensure they remained as objective as possible during 
consultations. Examples discussed included adhering to 
scripted information and only discussing innovative surgery if 
a patient specifically requested an alternative to conventional 
approaches:
You can word a new procedure, this is amazing, fantastic, 
amazing, it’s phenomenal and there’s no risks to it, and 
all the patients will say sure, yeah sign me up. Whereas, 
this is what we’re trying to look for, this is the benefits, 
these are the potential risks, so on and so forth. Then it 
becomes much more objective. (Surgeon 25, Thoracic, 
Male, Trust 14)
Of note however, the language used to describe conven-
tional surgical approaches during interviews highlights the 
potential for surgeons—although unintentionally—to influ-
ence treatment choice. For instance, terms such as ‘old fash-
ioned’ and ‘traditional’ were used by some when describing 
how they approached patient information provision:
I'll tell them, “We're going to try and do it like this. Is that 
okay? Do you have any objection? The alternative is we're 
going to do it the old- fashioned way, which is make a big 
cut in your- on your stomach wall.” (Surgeon 4, General 
and Upper Gastrointestinal Surgeon, Male, Trust 12)
Managing patient expectations
Surgeons felt that patients often had preferences for new 
treatments and expected these to deliver better outcomes. 
For instance those with experience of introducing robotically 
assisted surgery commonly reported that patients conveyed a 
strong preference for this approach. Consistent with this, one 
interviewee felt that patient demand for robotically assisted 
surgery was a driving factor for hospitals to invest in robotics.
Patients took to it [robotically assisted surgery] very well. 
I thought they might be a bit nervous about it, you know 
the robot taking over or going crazy…patients like the 
idea of technology. They equate the robot to being an 
advanced, superior treatment. (Surgeon 31, Colorectal, 
Male, Trust 8)
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Patients wanted to have robotic surgery, and if you didn’t 
have a robot, the patients would just go to a neighbour-
ing hospital that did. So, it’s really patient driven, so if you 
wanted to be a centre you have to have a robot. (Surgeon 
16, Urology, Male, Trust 2)
In general, interviewees felt patients held a misconception 
that ‘new’ surgical procedures and technologies are better 
than those normally provided. Some surgeons reported that 
patients had actively sought them out in order to receive 
innovative surgery:
They tend to have sought you out, because they want 
something different than the standard. So they’re kind of 
are willing to accept uncertainty and risk because they’ve 
already sought out that uncertainty and risk, if you know 
what I mean. (Surgeon 9, Upper Gastrointestinal, Male, 
Trust 3)
Several surgeons were concerned that patients did not 
understand that innovative procedures may carry uncertain-
ties in terms of risk and benefit. Managing patients’ prefer-
ences, particularly if they align with the personal preferences 
of the surgeon, appeared challenging for some:
When does a patient turn around and say, “Well I’ll 
have the old one?” And the answer is never, and that’s 
difficult, because they are immediately signing them-
selves up for an experiment. And how you describe 
that to patients is really difficult, because you’ve got 
all of your intrinsic biases yourself. Okay, go on then. 
(Surgeon 43, Orthopaedic, Male, Trust 2)
I don’t think I’ve had anyone say, “No, thank you.” I 
think most of them have gone, “I don’t mind being a 
guinea pig.” They always use that phrase (laughter). 
Makes me feel a little bit uncomfortable. (Surgeon 
36, Breast, Female, Trust 4)
DISCUSSION
This study provides novel insights into surgeons’ and gover-
nance representatives’ views on information provision in the 
context of innovative surgical procedures and represents a 
significant contribution to the limited empirical literature. 
Results highlight inconsistencies in how NHS Trusts govern 
how patients should be informed about innovative surgical 
procedures. Furthermore, interviews with surgeons suggest 
a lack of consistency in amount and quality of the provision 
of verbal and written information prior to delivery of inno-
vative surgical treatment. Data indicate a heavy reliance on 
surgeons to decide what and how information is communi-
cated to patients within some trusts. This conflicts with the 
recommendations published by the RCSEng, which suggest 
oversight committees should discuss information provision 
and consent with surgeons prior to approvals being granted.8 
Collectively, our results stress the need for better oversight 
and regulation of information provision in the context of 
innovative surgery. Without improved standards of infor-
mation provision, patients’ informed consent is potentially 
compromised. There is, however, particular complexity in 
understanding what innovation is, and when it might occur, 
that makes establishing these standards difficult.
Consistent with previous research, our findings suggest that 
surgeons may struggle to clearly define surgical innovation,13 
and this may impact on their approach to patient informa-
tion provision and consent. It can represent a continuum 
from standard practice through to true innovation. Rogers 
et al13 demonstrated that surgeons held no uniform view of 
surgical innovation, and showed the lack of agreement on 
the distinction between innovation and research. Our study 
highlights the implications of ambiguity—surgeons may use 
their own judgement as to what is innovative and therefore 
not discuss novel components of an operation with patients. 
In addition, procedures that were deemed innovative were 
sometimes introduced as part of routine clinical practice. 
This meant that information provided to patients was at 
the discretion of the surgeon, rather than an ethics review 
board and no peer review of the process. Birchley et al have 
suggested that instead of focusing on whether something is 
‘innovative’ or not, the potential risks and the ethical appro-
priateness of modifying surgical practice should be consid-
ered to ensure the safe translation of surgical innovation into 
clinical practice.29 Work is ongoing to better conceptualise 
what innovation is and determine when it is happening49—
although in the meantime we rely on surgeons’ views on what 
is innovative and how that influences their practice of infor-
mation provision.
Prior research has shown patients do not always feel fully 
informed about the different treatment options available to 
them.50 51 It is likely that the added complexity associated with 
innovative treatments (eg, unknown risks and benefits, lack 
of long- term data, limited surgeon experience of this tech-
nique) makes discussing treatments options particularly chal-
lenging for surgeons. This has an impact on the process of 
information provision within the context of gaining informed 
consent to undergo the procedure. As many innovations are 
undertaken within the context of clinical practice and not 
research, then the information provision is at the discretion 
of the surgeon. Study participants recognised the importance 
of communicating the risks and benefits, treatment alterna-
tives and novel status of a procedure to patients. However, it 
was less common for interviewees to identify prior training, 
experience with undertaking the procedure and the evidence 
base supporting the innovation as important components of 
consent in information provision. These elements of infor-
mation provision are recognised as key to gain informed 
consent.2 8 The variation observed in this study suggests there 
is a lack of clarity in guidance for surgeons on what should 
be disclosed during the content of informed consent discus-
sions in the context of innovative surgery, meaning that 
some patients are likely to be better informed than others 
when making treatment decisions. This is a concern given 
that information provision within the context of informed 
consent has been linked to patient satisfaction and rates of 
litigation following surgery.52–54
Aligning with previous research, our data suggest surgeons 
may not disclose their personal experience of performing 
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a procedure to patients and this is important to patients.12 
In this study few surgeons identified, or reported discussing, 
surgical experience and/or training as a component of 
information provision. While we cannot conclude from the 
current data, the disclosure of this information could lead 
to conversations regarding the surgical learning curve. Such 
discussions could help emphasise to patients that a proce-
dure is novel and there are potential uncertainties in terms 
of risks and benefits. Training programmes have been devel-
oped to enhance informed consent in RCTs,55 56 although 
none have focused on innovative surgical procedures. Our 
study suggests that surgeons may require training to raise 
awareness of the challenges of discussing novel procedures 
and provide support to overcome these.
To the best of our knowledge, this study is the first to explore 
healthcare professionals’ views of what information should be 
shared with patients during informed consent consultations 
in the context of innovative surgery. An important strength 
of the study is the sample of both surgeons and governance 
representatives, recruited from various surgical specialties, 
trust types and geographical locations. This allowed us to 
explore information provision and consent from different 
perspectives, and provided important insight into the role 
trust governance plays in patient information provision and 
consent. Nonetheless, there are potential limitations to the 
study that should be acknowledged. We cannot conclude 
exactly what information is communicated to patients during 
consultations from interview data alone. Future research 
should capture what actually happens in these interactions 
by audio recording clinician–patient consultations. Such 
methods have been used successfully in RCTs to improve 
the quality of informed consent and recruitment rates.56–58 
Furthermore, studies exploring patients’ views, particularly 
those who are offered or have received innovative surgery, 
are critical if we are to understand the type of information 
patients draw on when making decisions about their care. 
This work is currently being conducted by our research 
group as part of a larger research study exploring innovation 
in surgery.49 It is hoped that this research will aid the devel-
opment of ‘core information sets’ (minimum sets of infor-
mation that should be discussed with patients), which will 
ultimately support surgeons to discuss innovation and help 
catalyse the discussion of issues that are important to indi-
vidual patients.59
In conclusion, the study suggests that information provi-
sion for innovative surgery presents a challenge for surgeons. 
Our findings also highlight variation in how NHS Trusts 
govern information provision and consent practice for inno-
vative surgery, and further inconsistencies between the views 
of surgeons and governance representatives. When innova-
tions are introduced under the auspices of research, there 
are governance structures (eg, research ethics committees) 
in place to help ensure patient information is appropriate. 
However, innovation and modifications to surgery often take 
place without formal research approval, which raises the 
question of how well informed patients are prior to surgery. 
While the recent RCSEng guidelines for introducing new 
techniques and technologies represent an important step 
towards improving informed consent, our study suggests a 
need to develop support and training programmes to ensure 
that surgeons consistently deliver appropriate and compre-
hensive information to patients in the context of innovative 
surgery.
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